🔎 Trials Near Me

Home › Focal Segmental Glomerulosclerosis › Ohio

Focal Segmental Glomerulosclerosis clinical trials in Ohio

8 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in Ohio.

Cities in Ohio

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #20, Cleveland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07268638

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

  • Americare Kidney Institute - Brunswick, Brunswick
  • The Kidney and Hypertension Center, Cincinnati
  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 30, 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  • Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
RecruitingPhase 2
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

  • Akron Children's Hospital, Akron
Recruiting
Up to age 75 · All sexes · Updated Aug 28, 2026 · NCT04065438

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • Akron Children's Hospital, Akron
Recruiting
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT02235857

NEPTUNE Match Study

  • Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658

Nephrotic Syndrome Study Network

  • Cleveland Clinic, Cleveland
  • The Ohio State University Wexner Medical Center, Columbus
RecruitingObservational study
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • Nationwide Children's Hospital, Columbus
RecruitingPhase 2
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.